NEMAR copy of ds007864
You're viewing the NEMAR copy at v1.0.0.
Each OpenNeuro pull is a NEMAR major bump
(vN.0.0); intermediate versions are NEMAR-side fixes.
Neuroepo multisession Phase II and III
Multisession EEG and clinical dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (an erythropoietin formulation) in patients with Parkinson's disease. Participants were assessed at baseline and 9 months after the intervention, with cumulative NeuroEPO dose quantified and placebo coded as zero. The dataset supports analysis of treatment exposure, EEG-derived measures, and motor outcomes (MDS-UPDRS III).
AI-generated description, may include mistakesLoading demographics…
Coming soon. Per-file data-quality summaries are precomputed by the NEMAR processing pipeline. The static aggregate is on the way — tracked at nemar-cli#511.